论文部分内容阅读
2016年以来,草铵膦无论原药还是制剂,正经历着过山车式的价格震荡,但仍然有不少国内企业继续登记进入。截至2016年9月10日,我国批准登记并在有效期内的草铵膦原药产品生产企业已达到33家(其中2016年新登记5家),其中国外企业1家(德国拜耳作物科学公司),国内企业32家(分布于12个省份)。分别是:江苏省(16家):江苏辉丰农化股份有限公司、江苏皇马农化有限公司、江苏七洲绿色化工股份有限公司、江苏优士化学有限公司、南京红太阳生物化
Since 2016, glufosinate is undergoing roller coaster-type price fluctuations regardless of the original drug or preparation, but many domestic enterprises continue to register. As of September 10, 2016, 33 glufosinate-based drug product manufacturers have been registered and approved within China’s validity period (of which 5 were newly registered in 2016), including 1 foreign company (German Bayer CropScience) There are 32 domestic enterprises (distributed in 12 provinces). They are: Jiangsu Province (16): Jiangsu Huifeng Agrochemical Co., Ltd., Jiangsu Huangma Agrochemical Co., Ltd., Jiangsu Qizhou Green Chemical Co., Ltd., Jiangsu Youshi Chemical Co., Ltd., and Nanjing Red Sun Biotechnology Co., Ltd.